| scholarly article | Q13442814 |
| P50 | author | Philippe Colson | Q30322467 |
| P2093 | author name string | Valérie Moal | |
| René Gérolami | |||
| Christophe Picard | |||
| P433 | issue | 3 | |
| P921 | main subject | hepatitis E | Q326643 |
| liver disease | Q929737 | ||
| chronic liver disease | Q5113984 | ||
| hepatitis E virus | Q5731737 | ||
| P304 | page(s) | 622-624 | |
| P577 | publication date | 2008-12-25 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients | |
| P478 | volume | 50 |
| Q47316805 | A nationwide serosurvey of hepatitis E virus antibodies in the general population of Portugal. |
| Q37630325 | Autochthonous hepatitis e virus infections: a new transfusion-associated risk? |
| Q36134262 | Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus |
| Q26784271 | Chronic hepatitis E: A brief review |
| Q26996422 | Chronic hepatitis e virus infection and treatment |
| Q40085149 | Clinical Manifestations of Hepatitis E. |
| Q33703351 | Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors |
| Q38058285 | Emerging viral diseases in kidney transplant recipients |
| Q38751243 | First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 5: recipient monitoring and response plan for preventing diseas |
| Q56656388 | Hepatitis E |
| Q92637187 | Hepatitis E Virus Assembly and Release |
| Q35188601 | Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy |
| Q44299364 | Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study |
| Q45362400 | Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection |
| Q43523115 | Hepatitis E virus excretion can be prolonged in patients with hematological malignancies |
| Q43347427 | Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. |
| Q45364186 | Hepatitis E virus infection in patients infected with the human immunodeficiency virus |
| Q39155131 | Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors. |
| Q35817883 | Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France |
| Q93140759 | Hepatitis E: The nonendemic perspective |
| Q38066540 | Hepatitis E: source and route of infection, clinical manifestations and new developments |
| Q44298509 | Infection with hepatitis E virus in kidney transplant recipients in southeastern France |
| Q40507410 | Laboratory Diagnosis of HEV Infection |
| Q36171437 | Novel approach for detection of hepatitis E virus infection in German blood donors |
| Q42232143 | Past and current hepatitis E virus infection in renal transplant patients |
| Q40153625 | Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity |
| Q45356547 | Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients--a single-center experience |
| Q38268414 | Risk factors for hepatitis E virus infection and disease. |
| Q35582431 | Seroprevalence of hepatitis E among Iranian renal transplant recipients |
| Q57241777 | The emergence of hepatitis E virus in Europe |
| Q37960564 | The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. |
| Q37877930 | The molecular epidemiology of hepatitis E virus infection |
| Q35173590 | The occurrence and prevention of foodborne disease in vulnerable people. |
| Q33753481 | Xenotransplantation - A special case of One Health |
| Q38353549 | Xenotransplantation and Hepatitis E virus |
Search more.